Mandate

Vinge advises Intera Partners in connection with the investment in Yellow Elk

January 15, 2025

Vinge has advised the Nordic private equity firm Intera Partners in connection with its investment in the AI and data analytics firm Yellow Elk.

Yellow Elk offers high-level expertise within data analytics and AI, spanning from data engineering to machine learning, presentation, analysis and broader advisory, including enterprise and data architecture as well as data-driven change. Founded in 2018, Yellow Elk has a turnover of SEK 150 million and employs around 90 professionals in data and analytics in Sweden. Yellow Elk has been recognized by Dagens Industri as a fast-growing “Gasell” company for the past three years.

The transaction is subject to regulatory approvals.

Vinge’s team consisted of Jonas Johansson, Egil Svensson and Helena Liljenberg (M&A), Helena Göransson and Karl-Gustaw Tobola (Banking and Finance), Mario Saad and Jacob Eberil (Commercial Agreements), Simon Söderholm and Agnes Pigg (Employment), Johan Gavelin (IP), Katja Häglund (IT and GDPR), Madelene Andersson and Sara Franson (Real Estate), Daniel Wendelsson, Martin Hammarskiöld and Lovisa Arpi (Regulatory).

Read the client’s press release.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026